Biotechnology Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update – Lumos Pharma (NASDAQ:LUMO) Read more
Biotechnology MindMed Receives FDA ‘Breakthrough Therapy’ Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials – Compass Pathways (NASDAQ:CMPS), Mind Medicine (NASDAQ:MNMD) Read more
Biotechnology Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead’s and Merck’s Combo Therapy – Merck & Co (NYSE:MRK), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline – Lipella Pharmaceuticals (NASDAQ:LIPO) Read more
Biotechnology CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients – CASI Pharmaceuticals (NASDAQ:CASI) Read more
Biotechnology Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment – Compass Pathways (NASDAQ:CMPS) Read more
Biotechnology Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety – Incannex Healthcare (NASDAQ:IXHL) Read more
Biotechnology Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial – Compass Therapeutics (NASDAQ:CMPX) Read more
Biotechnology AXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation – Axim Biotechnologies (OTC:AXIM) Read more